文献
J-GLOBAL ID:201802222610690619
整理番号:18A1993442
慢性リンパ性白血病の治療未経験患者に対する単剤イブラチニブ対化学免疫療法レジメン:第3相試験の交差試験比較【JST・京大機械翻訳】
Single-agent ibrutinib versus chemoimmunotherapy regimens for treatment-naieve patients with chronic lymphocytic leukemia: A cross-trial comparison of phase 3 studies
著者 (26件):
Robak Tadeusz
(Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland)
,
Burger Jan A.
(The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Tedeschi Alessandra
(ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy)
,
Barr Paul M.
(Wilmot Cancer Institute, University of Rochester Cancer Center, Rochester, New York)
,
Owen Carolyn
(Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada)
,
Bairey Osnat
(Rabin Medical Center, Beilinson Hospital and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel)
,
Hillmen Peter
(The Leeds Teaching Hospitals, St. James’s Institute of Oncology, Leeds, UK)
,
Simpson David
(North Shore Hospital, Auckland, New Zealand)
,
Grosicki Sebastian
(School of Public Health, Silesian Medical University, Katowice, Poland)
,
Devereux Stephen
(King’s College Hospital, NHS Foundation Trust, London, UK)
,
McCarthy Helen
(Royal Bournemouth Hospital, Bournemouth, UK)
,
Coutre Steven E.
(Stanford University School of Medicine, Stanford, California)
,
Quach Hang
(St. Vincent’s Hospital, University of Melbourne, Melbourne, Australia)
,
Gaidano Gianluca
(Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy)
,
Maslyak Zvenyslava
(Institute of Blood Pathology and Transfusion Medicine of the Academy of Medical Sciences of Ukraine, Lviv, Ukraine)
,
Stevens Don A.
(Norton Cancer Institute, Louisville, Kentucky)
,
Moreno Carol
(Hospital de la Santa Creu i Sant Pau, Barcelona, Spain)
,
Gill Devinder S.
(Princess Alexandra Hospital, Brisbane, Australia)
,
Flinn Ian W.
(Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee)
,
Gribben John G.
(Barts Cancer Institute, Queen Mary University of London, London, UK)
,
Mokatrin Ahmad
(Pharmacyclics LLC, an AbbVie Company, Sunnyvale, California)
,
Cheng Mei
(Pharmacyclics LLC, an AbbVie Company, Sunnyvale, California)
,
Styles Lori
(Pharmacyclics LLC, an AbbVie Company, Sunnyvale, California)
,
James Danelle F.
(Pharmacyclics LLC, an AbbVie Company, Sunnyvale, California)
,
Kipps Thomas J.
(University of California San Diego, Moores Cancer Center, La Jolla, California)
,
Ghia Paolo
(Universita Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele, Milan, Italy)
資料名:
American Journal of Hematology
(American Journal of Hematology)
巻:
93
号:
11
ページ:
1402-1410
発行年:
2018年
JST資料番号:
E0721B
ISSN:
0361-8609
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)